Technologies by Susan Thomas
Microfluidic Device Enables Prediction of T-Cell Ability to Home and Engraft to Disease Tissues

Only a fraction of infused T cells makes it into targeted tumors

Sustained Lymphatic Drug Delivery System Potentially Improves Efficacy and Safety of Immunotherapy and Targeted Therapies

No effective lymphedema therapies currently exist and cancer immunotherapy lacks safety and efficacy

Developing Tumor Immune Microenvironments via Engineered Hydrogel
A biomaterial-programmed method for preclinical in vivo cancer immunotherapy evaluation
Novel Crosslinked Hydrogel Improves Efficacy and Side Effects of Cancer Treatment
An innovative immunotherapy method uses checkpoint inhibitors to advance current antitumor therapeutics